Evidence map›Paper›PMID 39176300›Full record

ArticleCurrent urology2024

Proficiency score as a predictor of early trifecta achievement during the learning curve of robot-assisted radical prostatectomy for high-risk prostate cancer: Results of a multicentric series.

Umberto Anceschi, Rocco Simone Flammia, Antonio Tufano, Michele Morelli, Antonio Galfano, Lorenzo Giuseppe Luciani, Leonardo Misuraca, Paolo Dell'Oglio, Gabriele Tuderti, Aldo Brassetti and 12 more

Abstract read
In one paragraph

Article in Current urology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Umberto AnceschiDepartment of Urology, IRCCS "Regina Elena" National Cancer Institute, Rome, Italy.
Rocco Simone FlammiaUrologic Clinic, Department of Maternal-Child and Urologic Sciences, Sapienza University of Rome, Italy.
Antonio TufanoUrologic Clinic, Department of Maternal-Child and Urologic Sciences, Sapienza University of Rome, Italy.
Michele MorelliOspedale Niguarda Ca' Granda, Department of Urology, Milan, Italy.
Antonio GalfanoOspedale Niguarda Ca' Granda, Department of Urology, Milan, Italy.
Lorenzo Giuseppe LucianiDepartment of Urology, APSS Santa Chiara Regional Hospital, Trento, Italy.
Leonardo MisuracaDepartment of Urology, IRCCS "Regina Elena" National Cancer Institute, Rome, Italy.
Paolo Dell'OglioOspedale Niguarda Ca' Granda, Department of Urology, Milan, Italy.
Gabriele TudertiDepartment of Urology, IRCCS "Regina Elena" National Cancer Institute, Rome, Italy.
Aldo BrassettiDepartment of Urology, IRCCS "Regina Elena" National Cancer Institute, Rome, Italy.
Maria Consiglia FerrieroDepartment of Urology, IRCCS "Regina Elena" National Cancer Institute, Rome, Italy.
Alfredo Maria BoveDepartment of Urology, IRCCS "Regina Elena" National Cancer Institute, Rome, Italy.
Riccardo MastroianniDepartment of Urology, IRCCS "Regina Elena" National Cancer Institute, Rome, Italy.
Francesco PrataDepartment of Urology, IRCCS "Regina Elena" National Cancer Institute, Rome, Italy.
Isabella SperdutiDepartment of Biostatistical Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
Giovanni PetraliaOspedale Niguarda Ca' Granda, Department of Urology, Milan, Italy.
Silvia SeccoOspedale Niguarda Ca' Granda, Department of Urology, Milan, Italy.
Ettore Di TrapaniOspedale Niguarda Ca' Granda, Department of Urology, Milan, Italy.
Daniele MatteviDepartment of Urology, APSS Santa Chiara Regional Hospital, Trento, Italy.
Tommaso CaiDepartment of Urology, APSS Santa Chiara Regional Hospital, Trento, Italy.
Aldo Massimo BocciardiOspedale Niguarda Ca' Granda, Department of Urology, Milan, Italy.
Giuseppe SimoneDepartment of Urology, IRCCS "Regina Elena" National Cancer Institute, Rome, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Recently, an innovative tool called "proficiency score" was introduced to assess the learning curve for robot-assisted radical prostatectomy (RARP). However, the initial study only focused on patients with low-risk prostate cancer for whom pelvic lymph node dissection (PLND) was not required. To address this issue, we aimed to validate proficiency scores of a contemporary multicenter cohort of patients with high-risk prostate cancer treated with RARP plus extended PLND by trainee surgeons. Material and methods: Between 2010 and 2020, 4 Italian institutional prostate-cancer datasets were merged and queried for "RARP" and "high-risk prostate cancer." High-risk prostate cancer was defined according to the most recent European Association of Urology guidelines as follows: prostate-specific antigen >20 ng/mL, International Society of Urological Pathology ≥4, and/or clinical stage (cT) ≥ 2c on preoperative imaging. The selected cohort (n = 144) included clinical cases performed by trainee surgeons (n = 4) after completing their RARP learning curve (50 procedures for low-risk prostate cancer). The outcome of interest, the proficiency score, was defined as the coexistence of all the following criteria: a comparable operation time to the interquartile range of the mentor surgeon at each center, absence of any significant perioperative complications Clavien-Dindo Grade 3-5, no perioperative blood transfusions, and negative surgical margins. A logistic binary regression model was built to identify the predictors of 1-year trifecta achievement in the trainee cohort. For all statistical analyses, a 2-sided Results: A proficiency score was achieved in 42.3% patients. At univariable level, proficiency score was associated with 1-year trifecta achievement (odds ratio, 8.77; 95% confidence interval, 2.42-31.7; Conclusions: Our findings support the use of proficiency scores in patients and require extended PLND in addition to RARP.

Indexed as

High-risk prostate cancerLearning curveRobot-assisted radical prostatectomyTrifecta

Identifiers

PMID39176300
PMCPMC11337992

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.